Release Date: 25/07/17 14:39 Summary: Appendix 4C - quarterly Price Sensitive: Yes Download Document 211.14KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%